SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694187-19-000038
Filing Date
2019-05-13
Accepted
2019-05-13 09:04:56
Documents
67
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ntgn-20190331x10q.htm 10-Q 1203979
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 14308
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 14517
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 9903
  Complete submission text file 0001694187-19-000038.txt   5443833

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ntgn-20190331.xml EX-101.INS 907474
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ntgn-20190331.xsd EX-101.SCH 48154
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ntgn-20190331_cal.xml EX-101.CAL 68382
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ntgn-20190331_def.xml EX-101.DEF 264662
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ntgn-20190331_lab.xml EX-101.LAB 611937
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ntgn-20190331_pre.xml EX-101.PRE 395101
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Filer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38551 | Film No.: 19817018
SIC: 2836 Biological Products, (No Diagnostic Substances)